JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Patterns of Cancer in Kurdistan - Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Patterns of Cancer in Kurdistan - Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq
Khoshnaw, Najmaddin; Mohammed, Hazha A; Abdullah, Dana A;
  PDF(new window)
 Abstract
Background: Cancer has become a major health problem associated with high mortality worldwide, especially in developing countries. The aim of our study was to evaluate the incidence rates of different types of cancer in Sulaymaniyah from January-2006 to January-2014. The data were compared with those reported for other middle east countries. Materials and Methods: This retrospective study depended on data collected from Hiwa hospital cancer registry unit, death records and histopathology reports in all Sulaymaniyah teaching hospitals, using international classification of diseases. Results: A total of 8,031 cases were registered during the eight year period, the annual incidence rate in all age groups rose from 38 to 61.7 cases/100,000 population/year, with averages over 50 in males and 50.7 in females. The male to female ratio in all age groups were 0.98, while in the pediatric age group it was 1.33. The hematological malignancies in all age groups accounted for 20% but in the pediatric group around half of all cancer cases. Pediatric cancers were occluding 7% of total cancers with rates of 10.3 in boys and 8.7 in girls. The commonest malignancies by primary site were leukemia, lymphoma, brain, kidney and bone. In males in all age groups they were lung, leukaemia, lymphoma, colorectal, prostate, bladder, brain, stomach, carcinoma of unknown primary (CUP) and skin, while in females they were breast, leukaemia, lymphoma, colorectal, ovary, lung, brain, CUP, and stomach. Most cancers were increased with increasing age except breast cancer where decrease was noted in older ages. High mortality rates were found with leukemia, lung, lymphoma, colorectal, breast and stomach cancers. Conclusions: We here found an increase in annual cancer incidence rates across the period of study, because of increase of cancer with age and higher rates of hematological malignancies. Our study is valuable for Kurdistan and Iraq because it provides more accurate data about the exact patterns of cancer and mortality in our region.
 Keywords
Cancer;incidence;epidemiology;Hiwa hospital;Sulaymaniyah-Iraq;
 Language
English
 Cited by
1.
Increased Trend of Haematological Malignancies in Kurdistan Region/Iraq,;;

Asian Pacific Journal of Cancer Prevention, 2016. vol.17. 8, pp.4181-4182 crossref(new window)
1.
Primary care in an unstable security, humanitarian, economic and political context: the Kurdistan Region of Iraq, BMC Health Services Research, 2017, 17, 1  crossref(new windwow)
 References
1.
Abdulbari B, Hanadi A, Rasul K, et al (2007). Patterns of cancer incidence among the population of Qatar:a worldwide comparative study. Asian Pac J Cancer Prev, 9, 19-24.

2.
Ahmed AS, Omiston S, Saieni PD (2015). Trends in the lifetime risk of developing cancer in Great Britain; Comparison of risk for those born in 1930 to 1960. Br J Cancer, 606 .

3.
Anzola M (2004). Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat, 11, 383-93. crossref(new window)

4.
Bener A, Alwalsh R, Miller CJ, et al (2001). Knowledge, attitudes, and practices related to breast cancer screening: asurvey of Arab women. J Cancer Educ, 16, 215-20.

5.
Boyle P (1995). Progress in preventing death from colorectal cancer [Editorial]. Br J Cancer, 72, 528-30. crossref(new window)

6.
Denic S, Bener A, Sabri S, et al (2005). Parental consanguinity and risk of breast cancer: a population-based case-control study. Med Sci Monit, 11, 415-9.

7.
Boyle P, Gray N, Zatonski W et al (2003). Tobacco: Public Health Disaster of the Twentieth Century, Oxford, UK, Oxford University Press 2003.

8.
Denny L (2005). The prevention of cervical cancer in developing countries. BJOG, 112, 1204-12. crossref(new window)

9.
Doll R, Peto R, Boreham J, et al (2005). Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer, 92, 426-9.

10.
El-Helal T, Bener A, Galadari I (1997). Pattern of cancer in the United Arab Emirates. Annals of Saudi Medicine, 17, 506-9.)

11.
Executive Board of the Health Ministers' Council, Cancer incidence report of Gulf Cooperation Council countries for the year 1998, Riyadh, Saudi Arabia, April 2002.

12.
Facer CA, Playfair JH (1989). Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res, 53, 33-72. crossref(new window)

13.
Faivre J, Dancourt V, Lejeune C, et al (2004). Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology, 126, 1674-80. crossref(new window)

14.
Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0 2004.

15.
Ferlay J, Autier P, Boniol M, et al (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 18, 581-92.

16.
Ferlay, J, Shin, HR., Bray, F, et.al. (2010), Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. crossref(new window)

17.
Fischbach W, Tacke W, Greiner A, et al (1997). Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet, 349, 31-2.

18.
Franco EL, Harper DM (2005). Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine, 23, 2388-94. crossref(new window)

19.
Jones SB (1999). Cancer in the developing world: a call to action. BMJ, 319, 505-8. crossref(new window)

20.
International Agency for Research on Cancer (2004). Monographs on the evaluation of carcinogenic risks to humans, vol 83. tobacco smoke and involuntary smoking. lyon, France: IARC 2004.

21.
Kahan E, Ibrahim AS, El Najjar K, et al (1997). Cancer patterns in the middle east--special report from the middle east cancer society. Acta Oncol, 36, 631-6. crossref(new window)

22.
Khoshnaw N, Francis B, Safar B, et al (2014) Cytogenetic response in chronic myeloid leukaemia patients treated with imatinib mesylate homolog-drugs: 6 year's transitional study. J Cancer Therapy, 5, 453-9. crossref(new window)

23.
Ma X, Yu H (2006). Global burden of cancer. Yale J Biol Med, 79, 85-94.

24.
Magrath I, Jain V, Bhatia K (1992). Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol, 3, 285-95.

25.
Magrath I, Jain V, Bhatia K, et al (1992). Epstein-barr virus and burkitt's lymphoma. Seminars in Cancer Biology, 3, 285-95.

26.
Magrath I, Litvak J (1993). Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst, 85, 862-74. crossref(new window)

27.
Majid R, Mohammed H, Hassan H, et al (2012). A populationbased study of Kurdish breast cancer in northern Iraq: Hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data. BMC Women's Health, 12, 16

28.
Middle East Cancer Consortium. Manual of standards for cancer registration.2005. Available at at: http://mecc.cancer.gov/MECC_Manual_of_Standards.PDF.

29.
Monzer B, Sepetdjian E, Saliba N, et al (2008). Charcoal emissions as a source of CO and carcinogenic PAH in mainstream narghile waterpipe smoke. Food Chem Toxicol, 46, 2991-5. crossref(new window)

30.
Othman RT, Abdulljabar R, Saeed A, et al (2011). Cancer incidence rates in the Kurdistan region/Iraq from 2007-2009. Asian Pac J Cancer Prev, 12, 1261-4.

31.
Parkin DM, Pisani P, Ferlay J (1999). Global cancer statistics. CA: Cancer J Clin, 49, 33-64.

32.
Plesnicar S, Plesnicar A (2001). Cancer: a reality in the emerging world. Semin Oncol, 28, 210-6. crossref(new window)

33.
Quinn MJ, d'Onofrio A, Moller B, et al (2003). Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol, 14, 1148-52. crossref(new window)

34.
Rastogi T, Hildesheim A, Sinha R (2004). Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer, 4, 909-17. crossref(new window)

35.
Salminen E, Izewska J, Andreo P (2005). IAEA's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol, 44, 816-24. crossref(new window)

36.
Sankaranarayanan R, Budukh AM, Rajkumar R (2001). Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ, 79, 954-62.

37.
Sener SF, Grey N (2005). The global burden of cancer. J Surg Oncol, 92, 1-3. crossref(new window)

38.
Shin HR, Ahn YO, Bae JM, et al (2002). Cancer incidence in Korea, Cancer Res Treat, 34, 405-8 crossref(new window)

39.
Stewart BW, Kleihues P (2003). International Agency for Research on Cancer, World cancer report, Lyon, France: IARC Press 2003.

40.
Siegel R, Ma J, Zou Z, et.al (2014), Cancer statistics, 2014. CA: A Cancer J Clin, 64, 9-29.

41.
World Health Organization, (2003), Global cancer rates could increase by 50% to 15 million by 2020, sciencedaily, 4 April 2003.

42.
www.sciencedaily.com/releases/2003/04/030404073045.htm

43.
www.werf-Ukorg/report/preliminary (2007), J Natl Cancer Inst, 95, 1258-61

44.
www.cia.gov/library/publications/the-world-factbook/geos/iz.html

45.
Zangana A, Garota S (2012). Risk factors of breast cancer in a sample of Kurdish women of Kurdistan Region - Iraq: a comparative study between pre-menopausal and postmenopausal women, Zanco. J Med Sci, 16, 3.